Skip to content
2000
Volume 32, Issue 10
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Antimicrobial resistance (AMR) is an important health concern rooted in antibiotic misuse and overuse, resulting in drug-resistant bacteria. However, resistance to these antimicrobials developed as soon as they were administered. Several variables lead to the progression of antimicrobial resistance (AMR), making it a multifaceted challenge for healthcare systems worldwide, such as erroneous diagnosis, inappropriate prescription, incomplete treatment, and many more. Getting an in-depth idea about the mechanism underlying AMR development is essential to overcome this. This review aims to provide information on how various enzymes or proteins aid in the antimicrobial resistance mechanisms and also highlight the clinical perspective of AMR, emphasizing its growing impact on patient outcomes, and incorporate the latest recent data from the World Health Organisation (WHO), underscoring the global urgency of the AMR crisis, with specific attention to trends observed in recent years. Additionally, it is intended to provide ideas about inhibitors that can inhibit the mechanism of antibiotic resistance and also to provide an idea about numerous computational resources available that can be employed to predict genes and/or proteins and enzymes involved in various antibiotic resistance mechanisms.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128415482250721112427
2025-08-05
2026-03-05

  • From This Site

    /content/journals/cpd/10.2174/0113816128415482250721112427
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MinariniL.A.D.R. Antimicrobial resistance as a global public health problem: How can we address it?Front. Public Health2020861284410.3389/fpubh.2020.612844 33282821
     [Google Scholar]
  2. UddinT.M. ChakrabortyA.J. KhusroA. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.J. Infect. Public Health202114121750176610.1016/j.jiph.2021.10.020 34756812
     [Google Scholar]
  3. NdagiU. FalakiA.A. AbdullahiM. LawalM.M. SolimanM.E. Antibiotic resistance: Bioinformatics-based understanding as a functional strategy for drug design.RSC Advances20201031184511846810.1039/D0RA01484B 35685616
     [Google Scholar]
  4. AlcockB.P. RaphenyaA.R. LauT.T.Y. CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database.Nucleic Acids Res.202048D1D517D525 31665441
     [Google Scholar]
  5. Guevara SalazarJ.A. Morán DíazJ.R. Ramírez SeguraE. Trujillo FerraraJ.G. What are the origins of growing microbial resistance? Both Lamarck and Darwin were right.Expert Rev. Anti Infect. Ther.202119556356910.1080/14787210.2021.1839418 33073640
     [Google Scholar]
  6. CatalanoA. IacopettaD. CeramellaJ. Multidrug resistance (MDR): A widespread phenomenon in pharmacological therapies.Molecules202227361610.3390/molecules27030616 35163878
     [Google Scholar]
  7. AbushaheenMA Muzaheed,Fatani AJ Antimicrobial resistance, mechanisms and its clinical significance.Dis. Mon.202066610097110.1016/j.disamonth.2020.100971 32201008
     [Google Scholar]
  8. D’CostaV.M. WrightG.D. Biochemical logic of antibiotic inactivation and modification.Antimicrob Drug Resist Mech Drug Resist201719711310.1007/978‑3‑319‑46718‑4_8
     [Google Scholar]
  9. MunitaJ.M. AriasC.A. Mechanisms of antibiotic resistance.Microbiol. Spectr.20164210.1128/microbiolspec.VMBF‑0016‑2015
     [Google Scholar]
  10. GauthierJ. VincentA.T. CharetteS.J. DeromeN. A brief history of bioinformatics.Brief. Bioinform.20192061981199610.1093/bib/bby063 30084940
     [Google Scholar]
  11. MaryamL. UsmaniS.S. RaghavaG.P.S. Computational resources in the management of antibiotic resistance: Speeding up drug discovery.Drug Discov. Today20212692138215110.1016/j.drudis.2021.04.016 33892146
     [Google Scholar]
  12. HoC.S. WongC.T.H. AungT.T. Antimicrobial resistance: A concise update.Lancet Microbe20256110094710.1016/j.lanmic.2024.07.010 39305919
     [Google Scholar]
  13. PrestinaciF. PezzottiP. PantostiA. Antimicrobial resistance: A global multifaceted phenomenon.Pathog. Glob. Health2015109730931810.1179/2047773215Y.0000000030 26343252
     [Google Scholar]
  14. C Reygaert WAn overview of the antimicrobial resistance mechanisms of bacteria.AIMS Microbiol.20184348250110.3934/microbiol.2018.3.482 31294229
     [Google Scholar]
  15. RamirezM.S. TolmaskyM.E. Aminoglycoside modifying enzymes.Drug Resist. Updat.201013615117110.1016/j.drup.2010.08.003 20833577
     [Google Scholar]
  16. FernándezL. HancockR.E.W. Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance.Clin. Microbiol. Rev.201225466168110.1128/CMR.00043‑12 23034325
     [Google Scholar]
  17. VarelaM.F. StephenJ. LekshmiM. Bacterial resistance to antimicrobial agents.Antibiotics202110559310.3390/antibiotics10050593 34067579
     [Google Scholar]
  18. GabibovA.G. DontsovaO.A. EgorovA.M. Overcoming antibiotic resistance in microorganisms: Molecular mechanisms.Biochemistry202085111289129110.1134/S0006297920110012 33280573
     [Google Scholar]
  19. HendersonP.J.F. MaherC. ElbourneL.D.H. EijkelkampB.A. PaulsenI.T. HassanK.A. Physiological functions of bacterial “multidrug” efflux pumps.Chem. Rev.202112195417547810.1021/acs.chemrev.0c01226 33761243
     [Google Scholar]
  20. SunJ. DengZ. YanA. Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations.Biochem. Biophys. Res. Commun.2014453225426710.1016/j.bbrc.2014.05.090 24878531
     [Google Scholar]
  21. EgorovA.M. UlyashovaM.M. RubtsovaM.Y. Bacterial enzymes and antibiotic resistance.Acta Nat2018104334810.32607/20758251‑2018‑10‑4‑33‑48 30713760
     [Google Scholar]
  22. SchaenzerA.J. WrightG.D. Antibiotic resistance by enzymatic modification of antibiotic targets.Trends Mol. Med.202026876878210.1016/j.molmed.2020.05.001 32493628
     [Google Scholar]
  23. PolikanovY.S. AleksashinN.A. BeckertB. WilsonD.N. The mechanisms of action of ribosome-targeting peptide antibiotics.Front. Mol. Biosci.201854810.3389/fmolb.2018.00048 29868608
     [Google Scholar]
  24. WachinoJ.I. DoiY. ArakawaY. Aminoglycoside Resistance.Infect. Dis. Clin. North Am.202034488790210.1016/j.idc.2020.06.002 33011054
     [Google Scholar]
  25. MorićI. SavićM. Ilić-TomićT. VojnovićS. BajkićS. VasiljevićB. rRNA methyltransferases and their role in resistance to antibiotics.J. Med. Biochem.2010292916517410.2478/v10011‑010‑0030‑y
     [Google Scholar]
  26. SalaikumaranM.R. BadigerV.P. BurraV.L.S.P. 16S rRNA methyltransferases as novel drug targets against tuberculosis.Protein J.20224119713010.1007/s10930‑021‑10029‑2 35112243
     [Google Scholar]
  27. StsiapanavaA. SelmerM. Crystal structure of ErmE - 23S rRNA methyltransferase in macrolide resistance.Sci. Rep.2019911460710.1038/s41598‑019‑51174‑0 31601908
     [Google Scholar]
  28. StogiosP.J. SavchenkoA. Molecular mechanisms of vancomycin resistance.Protein Sci.202029365466910.1002/pro.3819 31899563
     [Google Scholar]
  29. MoffattJ.H. HarperM. BoyceJ.D. Mechanisms of polymyxin resistance.Adv. Exp. Med. Biol.20191145557110.1007/978‑3‑030‑16373‑0_5
     [Google Scholar]
  30. ConnellS.R. TraczD.M. NierhausK.H. TaylorD.E. Ribosomal protection proteins and their mechanism of tetracycline resistance.Antimicrob. Agents Chemother.200347123675368110.1128/AAC.47.12.3675‑3681.2003 14638464
     [Google Scholar]
  31. Rodríguez-MartínezJ.M. MachucaJ. CanoM.E. CalvoJ. Martínez-MartínezL. PascualA. Plasmid-mediated quinolone resistance: Two decades on.Drug Resist. Updat.201629132910.1016/j.drup.2016.09.001 27912841
     [Google Scholar]
  32. DhindwalP. ThompsonC. KosD. A neglected and emerging antimicrobial resistance gene encodes for a serine-dependent macrolide esterase.Proc. Natl. Acad. Sci. USA20231208221982712010.1073/pnas.2219827120 36791107
     [Google Scholar]
  33. NagshettyK. ShilpaB.M. PatilS.A. ShivannavarC.T. ManjulaN.G. An overview of extended spectrum beta lactamases and metallo beta lactamases.Adv. Microbiol.2021111376210.4236/aim.2021.111004
     [Google Scholar]
  34. GolkarT. ZielińskiM. BerghuisA.M. Look and outlook on enzyme-mediated macrolide resistance.Front. Microbiol.20189194210.3389/fmicb.2018.01942 30177927
     [Google Scholar]
  35. MorarM. PengellyK. KotevaK. WrightG.D. Mechanism and diversity of the erythromycin esterase family of enzymes.Biochemistry20125181740175110.1021/bi201790u 22303981
     [Google Scholar]
  36. ZielińskiM. ParkJ. SlenoB. BerghuisA.M. Structural and functional insights into esterase-mediated macrolide resistance.Nat. Commun.2021121173210.1038/s41467‑021‑22016‑3 33741980
     [Google Scholar]
  37. Van BambekeF. BalziE. TulkensP.M. Antibiotic efflux pumps.Biochem. Pharmacol.200060445747010.1016/S0006‑2952(00)00291‑4 10874120
     [Google Scholar]
  38. HassanK.A. LiuQ. HendersonP.J.F. PaulsenI.T. Homologs of the Acinetobacter baumannii AceI transporter represent a new family of bacterial multidrug efflux systems.MBio201561e01982e1410.1128/mBio.01982‑14 25670776
     [Google Scholar]
  39. KimJ. CaterR.J. ChoyB.C. ManciaF. Structural insights into transporter-mediated drug resistance in infectious diseases.J. Mol. Biol.20214331616700510.1016/j.jmb.2021.167005 33891902
     [Google Scholar]
  40. NishinoK. YamasakiS. NakashimaR. ZwamaM. Hayashi-NishinoM. Function and inhibitory mechanisms of multidrug efflux pumps.Front. Microbiol.20211273728810.3389/fmicb.2021.737288 34925258
     [Google Scholar]
  41. ZhangW. FisherJ.F. MobasheryS. The bifunctional enzymes of antibiotic resistance.Curr. Opin. Microbiol.200912550551110.1016/j.mib.2009.06.013 19615931
     [Google Scholar]
  42. AhmedS.K. HusseinS. QurbaniK. Antimicrobial resistance: Impacts, challenges, and future prospects.Journal of Medicine, Surgery, and Public Health2024210008110.1016/j.glmedi.2024.100081
     [Google Scholar]
  43. AnnunziatoG. Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: A review.Int. J. Mol. Sci.20192023584410.3390/ijms20235844 31766441
     [Google Scholar]
  44. LawsM. ShaabanA. RahmanK.M. Antibiotic resistance breakers: Current approaches and future directions.FEMS Microbiol. Rev.201943549051610.1093/femsre/fuz014 31150547
     [Google Scholar]
  45. González-BelloC. RodríguezD. PernasM. RodríguezÁ. ColchónE. β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs.J. Med. Chem.20206351859188110.1021/acs.jmedchem.9b01279 31663735
     [Google Scholar]
  46. WongD. van DuinD. Novel beta-lactamase inhibitors: Unlocking their potential in therapy.Drugs201777661562810.1007/s40265‑017‑0725‑1 28303449
     [Google Scholar]
  47. BushK. Other β-lactam antibiotics.Antibiot. Chemother.201022624410.1016/b978‑0‑7020‑4064‑1.00015‑4
     [Google Scholar]
  48. ShapiroA.B. Kinetics of sulbactam hydrolysis by β-lactamases, and kinetics of β-lactamase inhibition by sulbactam.Antimicrob. Agents Chemother.20176112e016121710.1128/AAC.01612‑17 28971872
     [Google Scholar]
  49. BonomoR. RudinS.A. ShlaesD.M. Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases.FEMS Microbiol. Lett.19971481596210.1016/S0378‑1097(97)00013‑X 9066111
     [Google Scholar]
  50. SharmaA. GuptaV.K. PathaniaR. Efflux pump inhibitors for bacterial pathogens.Indian J. Med. Res.2019149212914510.4103/ijmr.IJMR_2079_17 31219077
     [Google Scholar]
  51. LamersR.P. CavallariJ.F. BurrowsL.L. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.PLoS One2013836066610.1371/journal.pone.0060666 23544160
     [Google Scholar]
  52. RindiL. Efflux pump inhibitors against nontuberculous mycobacteria.Int. J. Mol. Sci.20202112419110.3390/ijms21124191 32545436
     [Google Scholar]
  53. AnesJ. SivasankaranS.K. MuthappaD.M. FanningS. SrikumarS. Exposure to sub-inhibitory concentrations of the chemosensitizer 1-(1-Naphthylmethyl)-piperazine creates membrane destabilization in multi-drug resistant Klebsiella pneumoniae.Front. Microbiol.2019109210.3389/fmicb.2019.00092 30814979
     [Google Scholar]
  54. GrimseyE.M. PiddockL.J.V. Do phenothiazines possess antimicrobial and efflux inhibitory properties?FEMS Microbiol. Rev.201943657759010.1093/femsre/fuz017 31216574
     [Google Scholar]
  55. MahamoudA. ChevalierJ. Davin-RegliA. BarbeJ. PagèsJ.M. Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates.Curr. Drug Targets20067784384710.2174/138945006777709557 16842215
     [Google Scholar]
  56. StavriM. PiddockL.J.V. GibbonsS. Bacterial efflux pump inhibitors from natural sources.J. Antimicrob. Chemother.20075961247126010.1093/jac/dkl460 17145734
     [Google Scholar]
  57. DouaferH. AndrieuV. PhanstielO. BrunelJ.M. Antibiotic adjuvants: Make antibiotics great again!J. Med. Chem.201962198665868110.1021/acs.jmedchem.8b01781 31063379
     [Google Scholar]
  58. GeorgeA. GeorrgeJ.J. Viroinformatics: Databases and tools.Rec Trends Sci Tech20192019117126
     [Google Scholar]
  59. GeorrgeJ.J. MishraS.K. ChhetriT. RoyS. GurungK. Computational tools and software in drug discovery. In: Molecular modeling and docking techniques for drug discovery and design.USAIGI Global Scientific Publishing2025183216
     [Google Scholar]
  60. BalakrishnanA. MishraS.K. SharmaK. GaglaniC. GeorrgeJ.J. Intersecting peptidomics and bioactive peptides in drug therapeutics.Curr. Bioinform.202520210311910.2174/0115748936351054241010091822
     [Google Scholar]
  61. PappM. SolymosiN. Review and comparison of antimicrobial resistance gene databases.Antibiotics202211333910.3390/antibiotics11030339
     [Google Scholar]
  62. FlandroisJ.P. LinaG. DumitrescuO. MUBII-TB-DB: A database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.BMC Bioinformatics201415110710.1186/1471‑2105‑15‑107 24731071
     [Google Scholar]
  63. BoolchandaniM. D’SouzaA.W. DantasG. Sequencing-based methods and resources to study antimicrobial resistance.Nat. Rev. Genet.201920635637010.1038/s41576‑019‑0108‑4 30886350
     [Google Scholar]
  64. SahaS.B. UttamV. VermaV. u-CARE: User-friendly Comprehensive Antibiotic resistance Repository of Escherichia coli.J. Clin. Pathol.201568864865110.1136/jclinpath‑2015‑202927 25935546
     [Google Scholar]
  65. LakinS.M. DeanC. NoyesN.R. MEGARes: An antimicrobial resistance database for high throughput sequencing.Nucleic Acids Res.201745D1D574D58010.1093/nar/gkw1009 27899569
     [Google Scholar]
  66. FeldgardenM. BroverV. Gonzalez-EscalonaN. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence.Sci. Rep.20211111272810.1038/s41598‑021‑91456‑0 34135355
     [Google Scholar]
  67. GschwindR. Ugarcina PerovicS. WeissM. ResFinderFG v2.0: A database of antibiotic resistance genes obtained by functional metagenomics.Nucleic Acids Res.202351W1W493-50010.1093/nar/gkad384 37207327
     [Google Scholar]
  68. YangY. JiangX. ChaiB. ARGs-OAP: Online analysis pipeline for antibiotic resistance genes detection from metagenomic data using an integrated structured ARG-database.Bioinformatics201632152346235110.1093/bioinformatics/btw136 27153579
     [Google Scholar]
  69. ThaiQ.K. BösF. PleissJ. The lactamase engineering database: A critical survey of TEM sequences in public databases.BMC Genomics200910139010.1186/1471‑2164‑10‑390 19698099
     [Google Scholar]
  70. WidmannM. PleissJ. OelschlaegerP. Systematic analysis of metallo-β-lactamases using an automated database.Antimicrob. Agents Chemother.20125673481349110.1128/AAC.00255‑12 22547615
     [Google Scholar]
  71. NaasT. OueslatiS. BonninR.A. Beta-lactamase database (BLDB) - structure and function.J. Enzyme Inhib. Med. Chem.201732191791910.1080/14756366.2017.1344235 28719998
     [Google Scholar]
  72. SrivastavaA. SinghalN. GoelM. VirdiJ.S. KumarM. CBMAR: A comprehensive β-lactamase molecular annotation resource.Database20142014bau11110.1093/database/bau111 25475113
     [Google Scholar]
  73. WangG. ZietzC.M. MudgapalliA. WangS. WangZ. The evolution of the antimicrobial peptide database over 18 years: Milestones and new features.Protein Sci.20223119210610.1002/pro.4185 34529321
     [Google Scholar]
  74. WaghuF.H. Idicula-ThomasS. Collection of antimicrobial peptides database and its derivatives: Applications and beyond.Protein Sci.2020291364210.1002/pro.3714 31441165
     [Google Scholar]
  75. JhongJ.H. ChiY.H. LiW.C. LinT.H. HuangK.Y. LeeT.Y. dbAMP: An integrated resource for exploring antimicrobial peptides with functional activities and physicochemical properties on transcriptome and proteome data.Nucleic Acids Res.201947D1D285D29710.1093/nar/gky1030 30380085
     [Google Scholar]
  76. PirtskhalavaM. AmstrongA.A. GrigolavaM. DBAASP v3: Database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics.Nucleic Acids Res.202149D1D288D29710.1093/nar/gkaa991 33151284
     [Google Scholar]
  77. LvJ. LiuG. DongW. JuY. SunY. ACDB: An Antibiotic Combination DataBase.Front. Pharmacol.20221386998310.3389/fphar.2022.869983 35370670
     [Google Scholar]
  78. Arango-ArgotyG.A. DaiD. PrudenA. VikeslandP. HeathL.S. ZhangL. NanoARG: A web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes.Microbiome2019718810.1186/s40168‑019‑0703‑9 31174603
     [Google Scholar]
  79. Arango-ArgotyG.A. GuronG.K.P. GarnerE. ARGminer: A web platform for the crowdsourcing-based curation of antibiotic resistance genes.Bioinformatics20203692966297310.1093/bioinformatics/btaa095 32058567
     [Google Scholar]
  80. PinziL. TinivellaA. GagliardelliL. BeneventanoD. RastelliG. LigAdvisor: A versatile and user-friendly web-platform for drug design.Nucleic Acids Res.202149W1W326-3510.1093/nar/gkab385 34023895
     [Google Scholar]
  81. SnyderEE KampanyaN LuJ PATRIC: The VBI pathosystems resource integration center.Nucleic Acids Res200735DatabaseD401610.1093/nar/gkl858 17142235
     [Google Scholar]
  82. KyriakidisI. VasileiouE. PanaZ.D. TragiannidisA. Acinetobacter baumannii Antibiotic Resistance Mechanisms.Pathogens202110337310.3390/pathogens10030373 33808905
     [Google Scholar]
  83. ElfadadnyA. RagabR.F. AlHarbiM. Antimicrobial resistance of Pseudomonas aeruginosa: Navigating clinical impacts, current resistance trends, and innovations in breaking therapies.Front. Microbiol.202415137446610.3389/fmicb.2024.1374466 38646632
     [Google Scholar]
  84. GanT. ShuG. FuH. Antimicrobial resistance and genotyping of Staphylococcus aureus obtained from food animals in Sichuan Province, China.BMC Vet. Res.202117117710.1186/s12917‑021‑02884‑z 33902574
     [Google Scholar]
  85. BruceS.A. SmithJ.T. MydoshJ.L. Shared antibiotic resistance and virulence genes in Staphylococcus aureus from diverse animal hosts.Sci. Rep.2022121441310.1038/s41598‑022‑08230‑z 35292708
     [Google Scholar]
  86. ZhangX. TanL. OuyangP. Analysis of distribution and antibiotic resistance of Gram-positive bacteria isolated from a tertiary-care hospital in southern China: An 8-year retrospective study.Front. Microbiol.202314122036310.3389/fmicb.2023.1220363 37840716
     [Google Scholar]
  87. DadgostarP. Antimicrobial resistance: Implications and costs.Infect. Drug Resist.2019123903391010.2147/IDR.S234610 31908502
     [Google Scholar]
  88. ZhuY. HuangW.E. YangQ. Clinical perspective of antimicrobial resistance in bacteria.Infect. Drug Resist.20221573574610.2147/IDR.S345574 35264857
     [Google Scholar]
  89. AlgammalA. HettaH.F. MabrokM. BehzadiP. Editorial: Emerging multidrug-resistant bacterial pathogens “superbugs”: A rising public health threat.Front. Microbiol.202314113561410.3389/fmicb.2023.1135614 36819057
     [Google Scholar]
  90. LiuH. ShiK. WangY. Characterization of antibiotic resistance genes and mobile genetic elements in Escherichia coli isolated from captive black bears.Sci. Rep.2024141274510.1038/s41598‑024‑52622‑2 38302507
     [Google Scholar]
  91. NaylorN.R. AtunR. ZhuN. Estimating the burden of antimicrobial resistance: A systematic literature review.Antimicrob. Resist. Infect. Control2018715810.1186/s13756‑018‑0336‑y 29713465
     [Google Scholar]
  92. RaveendranK. VaiyapuriM. BadireddyM.R. Molecular tools for characterizing AMR pathogens. In: Handbook on antimicrobial resistance: Current status, trends in detection and mitigation measures.ChamSpringer2023125
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128415482250721112427
Loading
Antimicrobial Resistance: Enzymes, Proteins, and Computational Resources
Curr. Pharm. Des. 32, 731 (2026); https://doi.org/10.2174/0113816128415482250721112427
/content/journals/cpd/10.2174/0113816128415482250721112427
/content/journals/cpd/10.2174/0113816128415482250721112427
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): antibiotic resistance inhibitors; Antimicrobial resistance; databases; enzymes; genome; multidrug resistance

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test